Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Exocrine Pancreatic Cancer Carcinoma, Squamous Cell of Head and Neck Colorectal cancer NSCLC SCCHN CRC Pancreatic cancer Head and neck cancer Seattle Genetics HNSCC Carcinoma Pancreatic Neoplasms Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck Tisotumab vedotin Tisotumab Vedotin - Q3W Schedule Tisotumab Vedotin - 3Q4W Schedule Tisotumab Vedotin - 3Q4W/2Q4W Schedule
Lead Scientists at University of California Health
- May Cho (ucdavis)
Assistant Professor, Hematology and Oncology. Authored (or co-authored) 8 research publications.
- Edward Kim (ucdavis)
Associate Professor, Hematology and Oncology. Authored (or co-authored) 30 research publications.
- Jonathan W Riess (ucdavis)
Associate Professor, Hematology and Oncology. Authored (or co-authored) 73 research publications.
- accepting new patients
- Start Date
- Completion Date
- Seagen Inc.
- Phase 2
- Study Type
- Last Updated